Age Range: 18-55
Gender: Male, Female
Stipend: $3,850 for participants and $2,700 for caregivers
9 outpatient visits and 3 inpatient stays. Total duration up to 10.5 weeks.
Individuals who have a genetically confirmed diagnosis of Friedreich’s ataxia are needed for a phase 1b research study of an investigational medication.
You may be eligible if you:
- Are male or female between the ages of 18 to 55 years old (inclusive) at screening
- Are able to perform basic daily care, such as feeding yourself and personal hygiene, with minimal assistance
- Can sit upright with thighs together and arms crossed without requiring support on more than 2 sides
- Have genetically confirmed diagnosis of Friedreich’s Ataxia with homozygous GAA repeat expansions
Compensation for your time and travel per visit will be provided for qualified participants.
Click below to take our brief online questionnaire